Home>Topics>Drug Companies

Drug Companies

  1. All
  2. Commentary
  3. Video Reports
  4. Headlines
  1. Five Consensus Views that Could Prove Wrong in 2015

    Headlines

    Tue, 27 Jan 2015

    future articles, we'll explore other pharma and biotech option opportunities, such as how to use the option market to take advantage of blockbuster drug potential at Vertex Pharmaceuticals VRTX and Keryx Biopharmaceuticals KERX.

  2. BRIEF-Cosmo Pharmaceuticals announces results of withdrawal process

    Headlines

    Tue, 27 Jan 2015

    * Communicates results of withdrawal process and time line for pre-emption rights

  3. Shire shares jump as drug approval vindicates $5.2 bln NPS purchase

    Headlines

    Mon, 26 Jan 2015

    LONDON, Jan 26 (Reuters) - Shire Plc shares gained more than 3 percent on Monday following news U.S. regulators had approved NPS Pharmaceuticals Inc's drug Natpara, validating Shire's decision to buy...

  4. Regeneron/Sanofi cholesterol drug gets FDA priority review

    Headlines

    Mon, 26 Jan 2015

    Jan 26 (Reuters) - Regeneron Pharmaceuticals on Monday said U.S. health regulators accepted its application to review a potent cholesterol drug on a priority basis, potentially

  5. UPDATE 1-U.S. FDA approves NPS drug, in move validating Shire takeover deal

    Headlines

    Fri, 23 Jan 2015

    Jan 23 (Reuters) - The U.S. Food and Drug Administration has approved NPS Pharmaceuticals Inc's drug Natpara to treat a rare hormone disorder, validating a bet by Shire Plc , which recently agreed to acquire NPS for $5.2 billion.

  6. FDA approves NPS drug, in move validating Shire takeover deal

    Headlines

    Fri, 23 Jan 2015

    Jan 23 (Reuters) - The U.S. Food and Drug Administration has approved NPS Pharmaceuticals Inc.'s drug Natpara to treat a rare hormone disorder, validating a bet by Shire Plc , which recently agreed...

  7. BRIEF-Santhera Pharmaceuticals reports increased FY net sales of CHF 2.6 mln from sales of Raxone

    Headlines

    Fri, 23 Jan 2015

    * In FY company reported increased net sales of 2.6 million Swiss francs ($3 million)(2013: 1.3 million Swiss francs) from sales of Raxone

  8. Ousted Sanofi CEO gets 4.44 million euro severance package

    Headlines

    Thu, 22 Jan 2015

    PARIS (Reuters) - European pharmaceuticals group Sanofi on Thursday said it had agreed to pay 4.44 million euros ($5.06 million) in total to ousted chief executive Chris Viehbacher.

  9. UPDATE 1-Ousted Sanofi CEO gets 4.44 mln eur severance package

    Headlines

    Thu, 22 Jan 2015

    PARIS, Jan 22 (Reuters) - European pharmaceuticals group Sanofi on Thursday said it had agreed to pay 4.44 million euros ($5.06 million) in total to ousted chief executive Chris Viehbacher.

  10. Sanofi grants ousted CEO Viehbacher 2.96 mln eur severance payment

    Headlines

    Thu, 22 Jan 2015

    PARIS, Jan 22 (Reuters) - European pharmaceuticals group Sanofi said former chief executive Christopher Viehbacher would receive 2.96 million euros ($3.37 million) as a severance payment following his ouster last autumn.

« Prev12345Next »
Content Partners